| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6119477 | Journal of Clinical Virology | 2016 | 6 Pages |
Abstract
The 95% LOD by the triplex assay was 15 copies/reaction for DENV-1 and less than 10 copies/reaction for all other viruses. The triplex assay was 100% specific and did not amplify any of the other viruses tested. The assay was reproducible and adaptable to testing different specimen types including serum, plasma, urine, placental tissue, brain tissue and amniotic fluid. This assay can be easily implemented for diagnostic testing of patient samples, even in a high throughput laboratory.
Related Topics
Life Sciences
Immunology and Microbiology
Applied Microbiology and Biotechnology
Authors
Kanti Pabbaraju, Sallene Wong, Kara Gill, Kevin Fonseca, Graham A. Tipples, Raymond Tellier,